Physicians can ethically withhold information in situations where full disclosure of a diagnosis or treatment would cause great psychological harm to the patient.
Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
A pre-med student relates his family's experiences in trying to get his strong-willed grandfather to adhere to a strict medical care regimen for his chronic condition.
An ethical case explores whether a medical student doing a radiology rotation has a duty to inform a patient whose chest x-ray shows bony metastases that was not caught by the original radiologist or mentioned in the ED chart.
An ethical case explores whether a medical student doing a radiology rotation has a duty to inform a patient whose chest x-ray shows bony metastases that was not caught by the original radiologist or mentioned in the ED chart.